CIK 0001125345 · Non-accelerated filer<br>Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $129,086
- in 1 filing, $129K under 10b5-1 plans
Net −$129,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-07 | Peters Jeffrey Stuart Senior VP, GC, and Secretary | Option exercise | +6,001 | 19,712 | ||
| 2026-02-07 | Peters Jeffrey Stuart Senior VP, GC, and Secretary | Shares withheld for taxes | −2,317 | $1.81 | $4K | 17,395 |
| 2026-02-07 | Peters Jeffrey Stuart Senior VP, GC, and Secretary | Option exercise · Restricted Stock Unit | −6,001 | 11,999 | ||
| 2026-02-07 | Spitznagel Thomas Sr VP, Technical Ops | Option exercise | +6,001 | 27,403 | ||
| 2026-02-07 | Spitznagel Thomas Sr VP, Technical Ops | Shares withheld for taxes | −2,485 | $1.81 | $4K | 24,918 |
| 2026-02-07 | Spitznagel Thomas Sr VP, Technical Ops | Option exercise · Restricted Stock Unit | −6,001 | 11,999 | ||
| 2026-02-07 | Bonvini Ezio Sr VP, Research & CSO | Option exercise | +7,001 | 131,415 | ||
| 2026-02-07 | Bonvini Ezio Sr VP, Research & CSO | Shares withheld for taxes | −2,703 | $1.81 | $5K | 128,712 |
| 2026-02-07 | Bonvini Ezio Sr VP, Research & CSO | Option exercise · Restricted Stock Unit | −7,001 | 13,999 | ||
| 2026-02-07 | Risser Eric Blasius President and CEO | Option exercise | +6,668 | 62,657 | ||
| 2026-02-07 | Risser Eric Blasius President and CEO | Shares withheld for taxes | −2,575 | $1.81 | $5K | 60,082 |
| 2026-02-07 | Risser Eric Blasius President and CEO | Option exercise · Restricted Stock Unit | −6,668 | 13,332 | ||
| 2026-02-07 | Karrels James SVP and CFO | Option exercise | +6,334 | 193,135 | ||
| 2026-02-07 | Karrels James SVP and CFO | Shares withheld for taxes | −2,446 | $1.81 | $4K | 190,689 |
| 2026-02-07 | Karrels James SVP and CFO | Option exercise · Restricted Stock Unit | −6,334 | 12,666 | ||
| 2025-12-08 | Smith Beth Ann VP, Controller & Treasurer | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-08-20 | HEIDEN WILLIAM K Director | Purchase | +49,500 | $1.49 | $74K | 111,000 |
| 2025-08-19 | HEIDEN WILLIAM K Director | Purchase | +50,500 | $1.52 | $77K | 61,500 |
| 2025-08-15 | Peters Jeffrey Stuart Senior VP and General Counsel | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-08-15 | Spitznagel Thomas Sr VP, Technical Ops | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 |
Page 6 of 17 · 322 trades